Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-ischemic cerebral enhancing (NICE) lesions after flow diversion for intracranial aneurysms: a multicenter study.
Richter C, Möhlenbruch MA, Vollherbst DF, Taschner CA, Elsheikh S, Klisch J, Lobsien D, Bester M, Ramdani N, Kaiser DPO, Gerber JC, Schob S, Gazis A, Smirnov P, Scherlach C, Hoffmann KT, Gawlitza M. Richter C, et al. Among authors: scherlach c. J Neurointerv Surg. 2024 Oct 14;16(11):1174-1180. doi: 10.1136/jnis-2023-021176. J Neurointerv Surg. 2024. PMID: 38184369 Free PMC article.
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial.
Köhler W, Engelen M, Eichler F, Lachmann R, Fatemi A, Sampson J, Salsano E, Gamez J, Molnar MJ, Pascual S, Rovira M, Vilà A, Pina G, Martín-Ugarte I, Mantilla A, Pizcueta P, Rodríguez-Pascau L, Traver E, Vilalta A, Pascual M, Martinell M, Meya U, Mochel F; ADVANCE Study Group. Köhler W, et al. Lancet Neurol. 2023 Feb;22(2):127-136. doi: 10.1016/S1474-4422(22)00495-1. Lancet Neurol. 2023. PMID: 36681445 Clinical Trial.
Case report: Treatment of advanced CSF1-receptor associated leukoencephalopathy with hematopoietic stem cell transplant.
Bergner CG, Schäfer L, Vucinic V, Schetschorke B, Lier J, Scherlach C, Rullmann M, Sabri O, Classen J, Platzbecker U, Kühl JS, Barthel H, Köhler W, Franke GN. Bergner CG, et al. Among authors: scherlach c. Front Neurol. 2023 May 24;14:1163107. doi: 10.3389/fneur.2023.1163107. eCollection 2023. Front Neurol. 2023. PMID: 37292133 Free PMC article.
Interplay of tau and functional network connectivity in progressive supranuclear palsy: a [18F]PI-2620 PET/MRI study.
Aghakhanyan G, Rullmann M, Rumpf J, Schroeter ML, Scherlach C, Patt M, Brendel M, Koglin N, Stephens AW, Classen J, Hoffmann KT, Sabri O, Barthel H. Aghakhanyan G, et al. Among authors: scherlach c. Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):103-114. doi: 10.1007/s00259-022-05952-0. Epub 2022 Sep 1. Eur J Nucl Med Mol Imaging. 2022. PMID: 36048259
18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy.
Messerschmidt K, Barthel H, Brendel M, Scherlach C, Hoffmann KT, Rauchmann BS, Rullmann M, Marek K, Villemagne VL, Rumpf JJ, Saur D, Schroeter ML, Schildan A, Patt M, Beyer L, Song M, Palleis C, Katzdobler S, Fietzek UM, Respondek G, Scheifele M, Nitschmann A, Zach C, Barret O, Madonia J, Russell D, Stephens AW, Koglin N, Roeber S, Herms J, Bötzel K, Bartenstein P, Levin J, Seibyl JP, Höglinger G, Classen J, Sabri O; German Imaging Initiative for Tauopathies (GII4T). Messerschmidt K, et al. Among authors: scherlach c. J Nucl Med. 2022 Nov;63(11):1754-1760. doi: 10.2967/jnumed.121.262854. Epub 2022 Apr 14. J Nucl Med. 2022. PMID: 35422444 Free PMC article.
43 results